MannKind Corp
MNKD
#5739
Rank
A$1.87 B
Marketcap
A$5.82
Share price
-2.53%
Change (1 day)
-24.97%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -A$70.82 Million

According to MannKind Corp's latest financial reports the company's current earnings are A$0.39 Billion. In 2025 the company made an earning of A$2.12 Million a decrease over its 2024 earnings that were of A$46.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$70.82 Million-3431.24%
2025 A$2.12 M-95.39%
2024 A$46.1 M-394.09%
2023 -A$15.68 Million-88.13%
2022 -A$0.14 Billion8%
2021 -A$0.13 Billion40.84%
2020 -A$86.81 Million10.7%
2019 -A$78.42 Million-40.16%
2018 -A$0.14 Billion-26.04%
2017 -A$0.18 Billion-193.33%
2016 A$0.18 B-134.11%
2015 -A$0.56 Billion85.72%
2014 -A$0.3 Billion3.6%
2013 -A$0.29 Billion12.79%
2012 -A$0.26 Billion5.58%
2011 -A$0.25 Billion-5.72%
2010 -A$0.26 Billion-22.51%
2009 -A$0.34 Billion-27.37%
2008 -A$0.46 Billion3.36%
2007 -A$0.45 Billion27.18%
2006 -A$0.35 Billion101.63%
2005 -A$0.18 Billion50.46%
2004 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.52 B-14,421.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$34.72 B-47,339.69%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$52.52 B-71,562.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.15 B-13,917.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$0.88 B-1,298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-A$0.24 Billion 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA